Results

Refine your search to find tailored information about HCV treatments, guidelines, and patient care

AASLD/IDSA: Guidelines for Monitoring HCV Patients

Monitoring patients who are starting HCV treatment, are on treatment, or have completed therapy

AASLD/IDSA: Guidelines on HCV in Pregnancy

Recommendations for screening and monitoring women infected with HCV during pregnancy

AASLD/IDSA: Guidelines on HCV Testing and Linkage to Care

Recommendations for initial HCV testing, follow-up, patient counseling, and linkage to care

AASLD/IDSA: Guidelines on Incarcerated Populations

HCV testing and treatment in correctional settings

AASLD/IDSA: Guidelines on Men Who Have Sex With Men

Guidelines for HCV screening, treatment, and reinfection among men who have sex with men

AASLD/IDSA: Guidelines on People Who Inject Drugs

Recommendations for HCV screening, treatment, and reinfection among people who inject drugs

AASLD/IDSA: Simplified HCV Treatment Guidelines

Eligibility, recommended therapies, and monitoring steps for effective HCV treatment in adults new to therapy

Advice to Other Patients With HCV Infection

Helpful advice from patients with a history of drug use

American Liver Foundation

Discover current news and information on a variety of liver-related topics helping patients, friends, and families affected by liver disease

Anatomy of the Liver

Animation and handout on the structure and function of the liver

APRI: Aspartate Aminotransferase to Platelet Ratio Index

An online calculator for assessing liver fibrosis and cirrhosis

ASAM: American Society of Addiction Medicine

Resources and support for addiction medicine professionals, including education, advocacy, and clinical practice guidelines

Assessing Liver Damage Caused by HCV Infection: Common Laboratory Tests

Assessments to be conducted within 6 months prior to starting HCV treatment

AUDIT-C: Alcohol Use Disorders Identification Test

An online calculator to screen for risky drinking behavior and potential alcohol use disorders

Awareness of HCV Within the People Who Inject Drugs Community

People who inject drugs are often unaware of available treatment options

BMI: Body Mass Index

A screening tool to estimate body fat

CAGE Alcohol Questionnaire

A brief screening tool used to identify potential alcohol use disorders

CDC: Clinical Overview of Hepatitis C

Discover essential information about hepatitis C, including its transmission, prevention, and effective treatment options

CDC: Clinical Screening and Diagnosis for HCV

Screening, recommended tests, and interpretations of results

CDC: Division of Viral Hepatitis-2025 Strategic Plan

Objectives and strategies to achieve targets related to viral hepatitis prevention and management by 2025

CDC: HCV and Injection Drug Use

Injection drug use can be a risk factor for contracting HCV

CDC: HCV Public Resources

Read and download these fact sheets, posters, and educational materials on prevention, symptoms, and treatment

CDC: HCV Testing Fact Sheet

What to expect when getting tested

CDC: Hepatitis B Overview

Learn more about hepatitis B, including symptoms, spread, prevention, vaccination, and treatment

CDC: Hepatitis C Education Fact Sheet

What is hepatitis C, how it spreads, and how it can be prevented

CDC: Hepatitis C Overview

Learn the basics about hepatitis C, including its transmission, symptoms, testing, prevention, and treatment options

CDC: Men Who Have Sex With Men and Viral Hepatitis

Recommendations for men who have sex with men include vaccination and testing against viral hepatitis

CDC: People Who Inject Drugs and Viral Hepatitis

Information on people who use drugs and viral hepatitis, including CDC guidelines on screening, treatment, and resources

CDC: Recommendations for HCV Screening

In 2020, CDC recommended HCV testing for all adults, pregnant people, and people with risk factors

CDC: Sexual Transmission of Viral Hepatitis

Vaccination and testing for viral hepatitis are important for sexually active adults

CDC: Syringe Services Programs

A resource for assessing the need for Syringe Services Programs in a state, local, tribal, or territorial health department

CDC: Testing Sequence Flow Chart

Recommended testing sequence for identifying current HCV infection

CDC: Viral Hepatitis Among People Experiencing Homelessness

Homelessness impacts both physical and mental health, making it difficult to access health care

CDC: Viral Hepatitis Among People With HIV

People with HIV are at higher risk for complications and death from viral hepatitis infections

CDC: Viral Hepatitis Information for Gay and Bisexual Men

Gay and bisexual men are at increased risk for viral hepatitis and should take precautions to reduce their risk

CrCl: Creatinine Clearance

A test to estimate how effectively the kidneys filter creatinine from the blood

CTP: Child-Turcotte-Pugh

An online calculator to estimate the severity of cirrhosis

Emory Center for the Health of Incarcerated Persons

HCV prevalence is high among incarcerated individuals, highlighting the need for targeted efforts in correctional facilities

Extrahepatic Manifestations in HCV Infection

An overview on extrahepatic manifestations among patients with HCV with an emphasis on people who use drugs

FIB-4: Fibrosis-4 Index

An online calculator to estimate the risk of advanced liver disease

Fibrosis and Cirrhosis of the Liver

A summary of the causes of fibrosis, how it occurs, the different stages, and what cirrhosis is

Find a Syringe Exchange Program

Find harm reduction resources near you

Folleto para Pacientes con VHC
(HCV Patient Brochure)

Material centrado en el paciente que incluye detalles básicos sobre las causas, síntomas, características de la enfermedad, tratamiento y reinfección del VHC

(Patient-focused material containing basic details on causes, symptoms, disease characteristics, treatment, and reinfection of HCV)

GFR: Glomerular Filtration Rate

A tool to estimate overall kidney health

Glasgow Coma Scale

A neurological tool to assess a person’s level of consciousness after a head injury or other medical conditions affecting the brain

Guía de Evaluación Posterior al Tratamiento
(Posttreatment Follow-Up Guide)

Orientaciones sobre el seguimiento para pacientes que han sido tratados por infección por VHC, según el éxito del tratamiento

(Guidance on follow-up for patients who have been treated for HCV infection, based on treatment success)

Guía de Evaluación Previa al Tratamiento
(Pretreatment Assessment Guide)

Guía de AASLD/IDSA sobre el screening, diagnóstico, tratamiento y manejo del VHC (AASLD/IDSA guidance on HCV screening, diagnosis, treatment, and management)

Guía Para el Seguimiento Durante el Tratamiento
(On-Treatment Monitoring Guide)

Guía de la AASLD/IDSA para el monitoreo de pacientes con diabetes o en anticoagulantes (AASLD/IDSA guidance for monitoring patients with diabetes or on anticoagulants)

HCP Finder

An online physician finder based on your medical needs

HCV Basics for People Who Use Drugs

Explanation of the basics of hepatitis C transmission for people who use drugs

HCV Care for People Who Inject Drugs: Anne Ovrehus

An infectious disease physician provides testimony about their experience working in an opioid substitution therapy clinic

HCV Diagnosis and Assessments: Anthony Martinez and Tipu Khan

Learn about pretreatment assessments, liver fibrosis progression, and liver damage evaluation

HCV Epidemiology

An overview of hepatitis C epidemiology and the need to simplify the treatment cascade to improve patient care

HCV Landscape

An overview of changes in patients with HCV and treatments, emphasizing the role of nonspecialists in care

HCV Outreach in Addiction Medicine: Lorna Harrison

A clinical nurse specialist describes the importance of finding new ways to engage vulnerable patients in HCV care

HCV Patient Brochure

Patient-focused material containing basic details on causes, symptoms, disease characteristics, treatment, and reinfection of HCV

HCV Prevalence and Risk Factors: Anthony Martinez and Tipu Khan

Incidence of HCV infection and transmission among people who use drugs and other groups at risk

HCV Reinfection Rates in People Who Inject Drugs

Information on HCV reinfection rates and risk reduction strategies for people who inject drugs

HCV Screening and Diagnosis: Anthony Martinez and Tipu Khan

Discover who should be tested for HCV and the CDC recommendations for HCV diagnosis

HCV Screening for Infants and Children

An overview of the guidelines for the screening and diagnosis of infants and children with hepatitis C

HCV Screening Guide

An overview of the AASLD/IDSA guidelines for the screening and diagnosis of patients with hepatitis C

HCV Treatment and Posttreatment Assessments: Anthony Martinez and Tipu Khan

Learn about simplified HCV treatment and follow-up strategies after end of treatment

Hepatitis B Reactivation Guide

HBV reactivation causes, complications, assessments, and treatment considerations for patients with HCV/HBV coinfection

HHS: Viral Hepatitis National Strategic Plan for the United States (2021–2025)

Prevention, improved health outcomes, and reduced disparities to eliminate viral hepatitis as a public health threat by 2030

Identifying and Managing Patients With Cirrhosis

The differences between compensated and decompensated cirrhosis, how to measure the severity, and AASLD/IDSA guidelines

Identifying and Managing Patients Without Cirrhosis

The degree of hepatic fibrosis is key to determining the initial and follow-up management of patients

INHSU: Guidelines for HCV Care in Prison

Recommendations for prevention, testing, and treatment in correctional facilities

Liver Damage Assessments to Identify Patients for Simplified HCV Treatment

Noninvasive techniques that can be used to assess liver damage

MELD: Model for End-Stage Liver Disease

An online calculator to predict the likelihood of survival for patients >12 years with advanced liver disease

NASEN: Find a Needle Exchange Program

A tool to locate local Needle Exchange Programs

NASTAD: Community Navigation Model and Toolkit

A toolkit consisting of program protocols, data collection tools, and patient education materials

On-Treatment Monitoring Guide

AASLD/IDSA guidance for monitoring patients with diabetes or on anticoagulants

Overview of HCV Care in People Who Inject Drugs

Recommendations for screening and treatment of HCV infection in people who inject drugs

Posttreatment Follow-Up Guide

Guidance on follow-up for patients who have been treated for HCV infection, based on treatment success

Pretreatment Assessment Guide

AASLD/IDSA guidance on HCV screening, diagnosis, treatment, and management

Pretreatment Laboratory Assessments

AASLD/IDSA recommendations for pretreatment assessments following an HCV diagnosis

SAMHSA: Substance Abuse and Mental Health Services Administration

SAMHSA leads US public health efforts to improve behavioral health and the lives of individuals with mental and substance use disorders

Specialty Pharmacy Brochure

Essential information on specialty pharmacies and how to collaborate with them effectively

Stigma and HCV: A Barrier to Seeking Help

The stigma surrounding HCV is a major barrier to accessing HCV treatment

Stigma and HCV: Treatment Without Discrimination

Healthcare providers can reduce stigma and discrimination by showing compassion and practicing without judgment

Telemedicine: The “New Normal” for Managing HCV Care

A webinar with Dr. Tipu Khan on COVID-19's impact on HCV screening, diagnosis, care, and the role of telemedicine

The Impact of Cure Beyond Clinical Outcomes

Being cured from HCV may positively impact self-perceived mental health, physical well-being, and relationships with others

USPSTF: HCV Infection in Adolescents and Adults

US Preventive Services Task Force recommendations for screening adults aged 19 to 79 years

WHO: Combating HBV and HCV to Reach Elimination by 2030

Plans to increase prevention, testing, and treatment access to reduce new infections and mortality caused by HBV and HCV